U.S. pharma huge copyright scrapped two experimental weight loss products final yr—a at the time-each day tablet, lotiglipron, as a consequence of elevated liver enzymes and a two times-each day capsule, danuglipron, due to sturdy side effects—but CEO Albert Bourla has stated the company is set to “Participate in and earn” within the weight